Report Overview

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

Global Giant Cell Arteritis Treatment Market Outlook

The global giant cell arteritis treatment market was valued at USD 147.5 million in 2023, driven by increasing healthcare expenditure across the globe. It is expected to grow at a CAGR of 5.2% during the forecast period of 2024-2032, likely to reach a market value of USD 232.2 million by 2032.

Global Giant Cell Arteritis Treatment Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

North America Market to be Aided by the Increasing Prevalence of the Disease.

North America holds a significant share in the global market for giant cell arteritis treatment. This can be correlated to the rising incidences of the disease among the patients. Apart from North America, Europe is also a key market for giant cell arteritis treatment. The European market is being driven by the higher standards of living and health awareness among the consumers in the region. Meanwhile, the Asia Pacific market is expected to witness a healthy growth in the coming years as well. The growing developments and technological advancements in the healthcare industry in countries such as India and China are aiding the market growth in the Asia Pacific region.

Giant Cell Arteritis: Market Segmentation

Giant cell arteritis (GCA), also known as temporal arteritis, is a disease of inflammation in large blood vessels, usually around the brain and head. Symptoms of GCA may include pain in the temples, flu, headache, double vision, and difficulty in opening the mouth. However, the causes of the disease are yet unknown.

Global Giant Cell Arteritis Treatment Market By End Use

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Based on the treatment type, the market is broadly classified into:

  • Corticosteroid Therapy 
  • Others (Monoclonal Antibody)

By end-use, the market can be categorized into:

  • Hospitals
  • Clinics
  • ASC’s
  • Others

The EMR report looks into the regional markets of giant cell arteritis treatment like North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Global Giant Cell Arteritis Treatment Market  By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Growing Elderly Population Driving the Market Growth of Giant Cell Arteritis Treatment

The increasing prevalence of giant cell arteritis across the globe is driving the market for giant cell arteritis treatment. It is generally observed in the elderly population. The increasing disposable incomes, coupled with the rising aged population, are aiding the market growth. The increasing health awareness and improving standards of living in developing countries are adding to the market growth. Governments across the globe are investing huge amounts in research and development activities in the healthcare sector. The subsequent technological advancements and developments in the healthcare industry are anticipated to provide an impetus for the growth of the market. These factors are expected to propel the global market for giant cell arteritis treatment forward over the forecast period.

Key Industry Players in the Global Giant Cell Arteritis Treatment Market

The report presents a detailed analysis of the following key players in the global giant cell arteritis treatment market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • F. Hoffmann-La Roche Ltd.
  • Kiniksa Pharmaceuticals, Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Tianjin Tianyao Pharmaceutical Co., Ltd.
  • Others

The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Treatment Type
  • End Use
  • Region
Breakup by Treatment Type
  • Corticosteroid Therapy
  • Others (Monoclonal Antibody)
Breakup by End Use
  • Hospitals
  • Clinics
  • ASC’s
  • Others
Breakup by Region
  • North America
    • United States of America 
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others
Market Dynamics
  • SWOT Analysis
  • Porter's Five Forces Analysis
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • F. Hoffmann-La Roche Ltd.
  • Kiniksa Pharmaceuticals, Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Tianjin Tianyao Pharmaceutical Co., Ltd.
  • Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

View Our Best Selling Reports

Saudi Arabia Structural Steel Market

Europe Freeze-Dried Fruit Products Market

Steel Wire Rope Market

Animal Fat Market

Fulvic Acid Market

Industrial Hemp Market

North America Pallet Market

Saudi Arabia Electric Motors and Transformers Maintenance Market

Latin America Flexible Packaging Market

Electric Cargo Bikes Market

Giant Cell Arteritis Treatment Market Report Snapshots

Giant Cell Arteritis Treatment Market Size

Giant Cell Arteritis Treatment Market Growth

Giant Cell Arteritis Treatment Companies

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us today for customized, data-driven solutions tailored to your unique requirements!

Key Questions Answered in the Report

The global giant cell arteritis treatment market is expected to grow at a CAGR of 5.2%.

The major drivers of the industry, such as the increasing prevalence of the disease, rising disposable incomes, growing health consciousness, rapid urbanisation, and the growing elderly population, are expected to aid the market growth.

The key trend in the industry is the growing investments in the R&D activities of the healthcare sector.

The major regional markets for giant cell arteritis treatment are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

The major treatment types of giant cell arteritis in the market are corticosteroid therapy and others (monoclonal antibody).

The leading end use sectors for giant cell arteritis treatment in the market are hospitals, clinics, and ASC’s, among others.

The key players in the market include F. Hoffmann-La Roche Ltd., Kiniksa Pharmaceuticals, Ltd., Teva Pharmaceutical Industries Ltd., and Tianjin Tianyao Pharmaceutical Co., Ltd., among others.

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Pricing Plans

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,699

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,999

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,999

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,999

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

Strategic Solutions for Informed Decision-Making

Back to top

We’re here to help answer any questions about our products and services.

Contact us

Locations


United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Australia

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-120-433-0800

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63 287899028, +63 967 048 3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124